Home Cart 0 Sign in  

[ CAS No. 1403474-70-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1403474-70-3
Chemical Structure| 1403474-70-3
Structure of 1403474-70-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1403474-70-3 ]

Related Doc. of [ 1403474-70-3 ]

Alternatived Products of [ 1403474-70-3 ]

Product Details of [ 1403474-70-3 ]

CAS No. :1403474-70-3 MDL No. :MFCD28404679
Formula : C27H24N4O5 Boiling Point : -
Linear Structure Formula :- InChI Key :OWLFNOWZZXCCNU-UHFFFAOYSA-N
M.W : 484.50 Pubchem ID :135742013
Synonyms :

Calculated chemistry of [ 1403474-70-3 ]

Physicochemical Properties

Num. heavy atoms : 36
Num. arom. heavy atoms : 26
Fraction Csp3 : 0.19
Num. rotatable bonds : 9
Num. H-bond acceptors : 7.0
Num. H-bond donors : 1.0
Molar Refractivity : 134.42
TPSA : 112.24 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.66 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.21
Log Po/w (XLOGP3) : 5.06
Log Po/w (WLOGP) : 4.67
Log Po/w (MLOGP) : 3.51
Log Po/w (SILICOS-IT) : 5.14
Consensus Log Po/w : 4.32

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.97
Solubility : 0.000517 mg/ml ; 0.00000107 mol/l
Class : Moderately soluble
Log S (Ali) : -7.16
Solubility : 0.0000336 mg/ml ; 0.0000000693 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -9.27
Solubility : 0.00000026 mg/ml ; 0.0000000005 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.84

Safety of [ 1403474-70-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1403474-70-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1403474-70-3 ]
  • Downstream synthetic route of [ 1403474-70-3 ]

[ 1403474-70-3 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 1397836-41-7 ]
  • [ 105-58-8 ]
  • [ 1403474-70-3 ]
YieldReaction ConditionsOperation in experiment
86% With sodium ethanolate In ethanol; water at 60 - 65℃; for 1 h; The ethoxy oxime (II) (390 g; 851 mmol) is suspended in 3600 ml of diethyl carbonate. The suspension is heated up to 65°C. A solution of sodium ethoxide in ethanol (21 percent, 400 ml, 1072 mmol) is added dropwise to the reaction mixture at 65°C during 30 minutes. After completion of the addition the reaction mixture is agitated at 65°C for 30 minutes. The reaction mixture is cooled down to 60°C and water (1350 ml) is added. The resulting emulsionis agitated for at least 15 minutes. After separation of the layers the organic phase is extracted with water (1350 ml). The combined aqueous extracts are diluted with ethanol (1350 ml) and the temperature is adjusted to 40°C. Acetic acid (111 ml, 1940 mmcl) is added to the solution dropwise at 40°C during 30 minutes. The resuMing suspension is agitated at 40°C for 30 minutes and then cooled down to 20°C. The separated substance is aspirated and washed withwater (2 x 450 ml). The resulting product is then dried in a vacuum drier at 45°C. 397 g (86percent of the theoretical quantity, HPLC 95.8percent) of azilsartan ethyl ester (III) was obtained.
Reference: [1] Patent: WO2016/58563, 2016, A1, . Location in patent: Page/Page column 7
[2] Patent: WO2012/139536, 2012, A1, . Location in patent: Page/Page column 21
  • 2
  • [ 1403474-75-8 ]
  • [ 1403474-70-3 ]
YieldReaction ConditionsOperation in experiment
93% With potassium carbonate In dimethyl sulfoxide at 20℃; for 3 h; Example 9Ethyl 2-ethoxy-l -((2'-(5-oxo-4,5-dihydro-l ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-lH- benzo[tf)imidazole-7-carboxylate of formula lbUsing the procedure described in Example 6 ethyl 2-ethoxy-l -((2'-(N'-(ethoxycarbonyloxy)- carbamimidoyl)biphenyl-4-yl)methyl)-lH-benz[i/]imidazole-7-carboxylate of formula VIbb; R' = Et) was converted to ethyl 2-ethoxy-l -((2'-(5-oxo-4,5-dihydro-l ,2,4-oxadiazol-3- yl)biphenyl-4-yl)methyl)-l H-benzo[t/]imidazole-7-carboxylate of formula lb. 93.0percent of a compound with the melting point of 179 to 182°C were obtained containing 97.8percent of a product of formula lb according to HPLC. NMR (500 MHz, DMSO) δ (ppm): 12.40 (s, lH, NH), 7.69 (dd, J = 7.9, 1.2 Hz, 1H, Ar), 7.50 (m, 1H, Ar), 7.44 (dd, J = 7.9, 1.2 Hz, 1H, Ar), 7.43-7.40 (m, 4H, Ar), 7.35 (d, J = 7.7 Hz, 1 H, Ar), 7.19 (t, J = 7.9 Hz, 1H, Ar), 6.95 (d, J = 8.3 Hz, 2H, Ar), 6.61 (bs, 2H, NH2), 5.57 (s, 2H, N-CH2-Ar), 4.60 (q, J = 7.1 Hz, 2H, COOCH2CH3), 4.18 (q, J = 7.1 Hz, 2H, OCH2CH3), 1.39 (t, J = 7.1 Hz, 3H, COOCH2CH3), 1.16 (t, J = 7.1 Hz, 3H, OCH2CH3).
4.3 g at 110 - 115℃; for 2 h; A mixture of ethyl 2-ethoxy-l-((2'-(N'-((ethoxycarbonyl)oxy)carbamimidoyl)-[biphenyl]- 4-yl)methyl)-lH-benzoimidazole-7-carboxylate (compound V; Ri= R2=ethyl) (5 g), and dibutyl amine (30 ml) was heated at 110-115°C for 2 hours. The reaction mixture cooled to 25-30°C and stirred for one hour. The solid was filtered, washed with ethyl acetate and dried. Yield: 4.3 g.
Reference: [1] Patent: WO2012/139535, 2012, A1, . Location in patent: Page/Page column 16
[2] Journal of Heterocyclic Chemistry, 2013, vol. 50, # 4, p. 929 - 936
[3] Patent: WO2014/49512, 2014, A2, . Location in patent: Page/Page column 8
[4] Patent: CN108912109, 2018, A, . Location in patent: Paragraph 0094; 0096
[5] Patent: CN108640911, 2018, A, . Location in patent: Paragraph 0033; 0035; 0096-0233
  • 3
  • [ 75-44-5 ]
  • [ 1397836-41-7 ]
  • [ 1403474-70-3 ]
YieldReaction ConditionsOperation in experiment
82.5% With triethylamine In 1,4-dioxane; toluene at 50℃; for 8 h; Example 20 Ethyl 2-ethoxy-l -((2'-(5-oxo-4,5-dihydro- l ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- l H- benzo[cf]imidazole-7-carboxylate of formula lbA 20 percent solution of phosgene in toluene (0.5 ml, 1 mmol) was added to a mixture of ethyl 2- ethoxy- l -((2'-((hydroxyamino)iminomethyl)biphenyl-4-yl)methyl)- l H-benzo[i/|imidazole-7- carboxylate (of formula Vb; 0.23 g, 0.5 mmol), dioxan (5 ml) and triethylamine (0.2 g, 2 mmol) and the mixture was stirred in a closed pressure tube at 50 °C for 8 hours. After cooling down, the solution was bubbled with nitrogen for 8 hours. After evaporation of the solvent the residue was triturated with water ( 10 ml), the resulting turbid solution was acidified with acetic acid and extracted with ethyl acetate (4 x 25 ml). After washing with brine the extract was dried with MgS04 and the obtained evaporation residue was crystallized from ethyl acetate. 0.20 g (82.5 percent) of a product was obtained containing 98.4 percent of the compound of formula lb according to HPLC
Reference: [1] Patent: WO2012/139536, 2012, A1, . Location in patent: Page/Page column 23
  • 4
  • [ 1397836-41-7 ]
  • [ 105-58-8 ]
  • [ 1403474-70-3 ]
YieldReaction ConditionsOperation in experiment
76% With sodium ethanolate In ethanol at 80℃; for 2 h; The starting amidoxime (IV) was suspended in diethyl carbonate (30 g) and sodium ethoxide (21 percent in ethanol, 9 g) was added. The mixture was heated at 80°C for 2h, 20 ml of the solvent was removed by distillation, ethanol (20 ml), water (20 ml) and acetic acid (3 g) and more water (20 ml) were added. The suspension was stirred at 50°C for 1 h and cooled to 25°C. 8 g (76 percent) of the product was obtained.
Reference: [1] Patent: WO2014/48404, 2014, A1, . Location in patent: Page/Page column 10
  • 5
  • [ 1397836-41-7 ]
  • [ 530-62-1 ]
  • [ 1403474-70-3 ]
YieldReaction ConditionsOperation in experiment
95% With proton sponge In dimethyl sulfoxide at 20℃; for 3 h; Example 6Ethyl 2-ethoxy- l -((2'-(5-oxo-4,5-dihydro-l ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- lH- benzo[c/]imidazole-7-carboxylate of formula lbThe corresponding base (0. 1 g) was added to a mixture of ethyl 2-ethoxy- l -((2'- ((hydroxyamino)iminomethyl)biphenyl-4-yl)methyl)- l / -benzo[i ]imidazole-7-carboxylate (of formula Vb; 0.23 g, 0.5 mmol), DMSO (3 ml) and carbonyldiimidazole (0.1 g, 0,6 mmol) in a reaction vial under stirring and the mixture was stirred at the room temperature for 3 hours. Then, the content of the vial was poured into water (10 ml) and, after acidification with acetic acid, the separated solids were aspirated and washed with water. The yields and purity of the products are summarized in Table III. Table III - Yield and purity of the product of Example 6
Reference: [1] Organic Process Research and Development, 2013, vol. 17, # 1, p. 77 - 86
[2] Patent: WO2012/139536, 2012, A1, . Location in patent: Page/Page column 13-14
  • 6
  • [ 1397836-41-7 ]
  • [ 530-62-1 ]
  • [ 1403474-70-3 ]
YieldReaction ConditionsOperation in experiment
98.7 g With 1,8-diazabicyclo[5.4.0]undec-7-ene In tetrahydrofuran at 20℃; for 2 h; Example 1Prepared Synthesis of 2-ethoxy-3 - [[2 '- (N-benzyloxymethylidene) biphenyl-4-yl] methyl] benzimidazole-4-carboxylate,Into the reaction bottle,Add 209.8gCDI, 134ml DBU and 4.5L THF, room temperature reaction 2h, the reaction is completed. 4.5 L of water, 4.5 L of ethyl acetate was extracted and the organic phases were combined.Respectively, saturated NaHC03, saturated NaCl solution, dry anhydrous sodium sulfate organic phase, evaporated to dry organic solvent. Beaten with acetone, filtered and dried to obtain 98.7 g of a product.
Reference: [1] Patent: CN103664921, 2016, B, . Location in patent: Paragraph 0047-0049; 0050-0052
  • 7
  • [ 1403474-75-8 ]
  • [ 1403474-70-3 ]
  • [ 147403-03-0 ]
YieldReaction ConditionsOperation in experiment
39.3 %Chromat. With sodium ethanolate In dimethyl sulfoxide at 20℃; for 4 h; Example 5Ethyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1 H- benzo[c ]imidazole-7-carboxylate of formula lb0.05 g of the corresponding base was added to a mixture of 0.2 g of ethyl 2-ethoxy- l -((2'-(N'- (ethoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)- l -benz[(i]imidazole-7- carboxylate (of formula VIbb; R' = Et) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. Table II - Yield and purity of the product of Example 5
Reference: [1] Patent: WO2012/139535, 2012, A1, . Location in patent: Page/Page column 13-14
  • 8
  • [ 139481-41-7 ]
  • [ 1403474-70-3 ]
Reference: [1] Organic Process Research and Development, 2013, vol. 17, # 1, p. 77 - 86
[2] Patent: CN103664921, 2016, B,
[3] Patent: CN103664920, 2016, B,
[4] Patent: CN103664920, 2016, B,
[5] Patent: CN103664920, 2016, B,
[6] Patent: CN103664920, 2016, B,
[7] Patent: CN103664920, 2016, B,
[8] Patent: CN103664920, 2016, B,
[9] Patent: CN103664792, 2016, B,
[10] Patent: CN103664792, 2016, B,
[11] Patent: CN108912109, 2018, A,
[12] Patent: CN108640911, 2018, A,
  • 9
  • [ 1397836-41-7 ]
  • [ 1403474-70-3 ]
Reference: [1] Patent: CN103664920, 2016, B,
[2] Patent: CN103664920, 2016, B,
[3] Patent: CN103664920, 2016, B,
[4] Patent: CN108912109, 2018, A,
[5] Patent: CN108640911, 2018, A,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 1403474-70-3 ]

Azilsartan Related Intermediates

Chemical Structure| 114772-53-1

[ 114772-53-1 ]

4'-Methyl-[1,1'-biphenyl]-2-carbonitrile

Chemical Structure| 147403-52-9

[ 147403-52-9 ]

Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Chemical Structure| 114772-54-2

[ 114772-54-2 ]

4'-(Bromomethyl)-[1,1'-biphenyl]-2-carbonitrile

Chemical Structure| 150058-27-8

[ 150058-27-8 ]

Methyl 2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Chemical Structure| 107582-20-7

[ 107582-20-7 ]

Methyl 2,3-diaminobenzoate

Related Functional Groups of
[ 1403474-70-3 ]

Aryls

Chemical Structure| 147403-52-9

[ 147403-52-9 ]

Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.98

Chemical Structure| 147403-65-4

[ 147403-65-4 ]

Methyl 2-ethoxy-1-((2'-(N-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.84

Chemical Structure| 139481-41-7

[ 139481-41-7 ]

Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.72

Chemical Structure| 139481-44-0

[ 139481-44-0 ]

Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.71

Chemical Structure| 139481-72-4

[ 139481-72-4 ]

2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid

Similarity: 0.67

Ethers

Chemical Structure| 147403-52-9

[ 147403-52-9 ]

Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.98

Chemical Structure| 147403-65-4

[ 147403-65-4 ]

Methyl 2-ethoxy-1-((2'-(N-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.84

Chemical Structure| 139481-41-7

[ 139481-41-7 ]

Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.72

Chemical Structure| 139481-44-0

[ 139481-44-0 ]

Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.71

Chemical Structure| 139481-72-4

[ 139481-72-4 ]

2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid

Similarity: 0.67

Amides

Chemical Structure| 147403-52-9

[ 147403-52-9 ]

Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.98

Chemical Structure| 866084-31-3

[ 866084-31-3 ]

tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate

Similarity: 0.56

Chemical Structure| 144657-66-9

[ 144657-66-9 ]

tert-Butyl 3-formyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate

Similarity: 0.56

Chemical Structure| 211915-84-3

[ 211915-84-3 ]

Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate

Similarity: 0.55

Chemical Structure| 1377049-84-7

[ 1377049-84-7 ]

Methyl ((2S)-1-((2S,5S)-2-(9-(2-((2S,4S)-1-((2R)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

Similarity: 0.55

Esters

Chemical Structure| 147403-52-9

[ 147403-52-9 ]

Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.98

Chemical Structure| 147403-65-4

[ 147403-65-4 ]

Methyl 2-ethoxy-1-((2'-(N-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.84

Chemical Structure| 139481-41-7

[ 139481-41-7 ]

Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.72

Chemical Structure| 139481-44-0

[ 139481-44-0 ]

Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.71

Chemical Structure| 139481-69-9

[ 139481-69-9 ]

Methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.65

Related Parent Nucleus of
[ 1403474-70-3 ]

Oxadiazoles

Chemical Structure| 147403-52-9

[ 147403-52-9 ]

Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.98

Benzimidazoles

Chemical Structure| 147403-52-9

[ 147403-52-9 ]

Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.98

Chemical Structure| 147403-65-4

[ 147403-65-4 ]

Methyl 2-ethoxy-1-((2'-(N-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.84

Chemical Structure| 139481-41-7

[ 139481-41-7 ]

Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.72

Chemical Structure| 139481-44-0

[ 139481-44-0 ]

Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.71

Chemical Structure| 139481-72-4

[ 139481-72-4 ]

2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid

Similarity: 0.67